Data / Form D filings / Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc.: Form D filings
Cardiol Therapeutics Inc., a company in Oakville, Ontario, Canada, filed 5 Form D notices with the SEC between 2017 and 2025. The latest, on November 4, 2025, reports $760,000 sold of a $8.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2265 UPPER MIDDLE ROAD EAST, Suite 602, Oakville, Ontario, Canada, L6H 0
- Phone
- (289) 910-0850
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1702123
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | New notice | $8,471,875 | $760,000 | $7,711,875 | 7 | Oct 17, 2025 | sec.gov |
| Dec 15, 2020 | New notice | $9,129,776 | $829,139 | $8,300,637 | 2 | Jun 4, 2020 | sec.gov |
| Jan 4, 2019 | New notice | $8,423,198 | $3,662,260 | $4,760,938 | 9 | Dec 20, 2018 | sec.gov |
| Sep 29, 2017 | New notice | $680,000 | $680,000 | 36 | Sep 15, 2017 | sec.gov | |
| Mar 29, 2017 | New notice | $55,658 | $55,658 | 1 | Mar 8, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Guillermo Torre-Amione | Director | |
| David Elsley | Executive Officer, Director | |
| Chris Waddick | Executive Officer, Director | |
| Teri Loxam | Director | |
| Jennifer Chao | Director | |
| Bernard Lim | Executive Officer | |
| Peter Pekos | Director | |
| Colin Stott | Director | |
| Andrew Hamer | Executive Officer | |
| Tim Garnett | Director |
Every Form D from the week of Nov 3, 2025 · All recent Other filings
Read from SEC EDGAR. Amount sold is what Cardiol Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.